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CASE REPORT
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ABSTRACT
Proliferative verrucous leukoplakia (PVL) was first described
by Hansen in 1985, is a clinical form of oral leukoplakia defined
by its progressive features, and potential to develop into cancer.
PVL behaves in a more aggressive and relentless manner than
the more innocuous white oral lesions that it can resemble
clinically. In this paper, we report a case of PVL transforming
into squamous cell carcinoma.
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INTRODUCTION
Proliferative verrucous leukoplakia (PVL) is a rare oral
leukoplakia, principally characterized by chronic
proliferation, multiple occurrences and refractoriness to
treatment. Its rate of malignant transformation is extremely
high.1 The characteristics of its clinical and pathological
progress are considered vital basis for the diagnosis of PVL
because there are no particular differences between the
pathological changes of PVL and those of oral verrucous
leukoplakia (OVL).2,3 Hansen et al first described PVL as
those lesions characterized by having a high risk of
malignant transformation.4 PVL grows slowly and can take
up to 7.8 years to become cancerous. The process is
irreversible ad usually progresses to cancer, this warrants
attention.1 In this paper, we report a case of PVL transforming
into squamous cell carcinoma in a span of 6 months.
CASE REPORT
A 35-year-old male patient (Fig. 1) visited to oral medicine
with a chief compliant of white patches on his left cheek
and palate since 6 months with history of smoking, gutka
chewing and consumption of 90 ml alcohol every day. On
intraoral examination a raised corrugated white patch was
seen on the left buccal mucosa extending the whole of the
left buccal mucosa as well as the left hard palate and gingiva
with respect to upper left maxillary molars which is
nonscrapable (Figs 2 and 3), provisionally diagnosed as
homogenous leukoplakia of the left buccal mucosa and hard
plate.
10.5005/jp-journals-10026-1081
Fig. 1: Profile photograph of the patient
Fig. 2: Lesion extending the whole of the left buccal mucosa
Fig. 3: Lesion on the hard palate and gingiva of maxillary second
quadrant molar teeth
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HISTOPATHOLOGY
Incisional biopsy of the lesion from the left buccal mucosa
and palate was done, the hematoxylin and eosin (H&E)
sections showed epithelial proliferation in the form of
exophytic projections covered by hyperorthokeratotic
stratified squamous epithelium and in few areas there is an
endophytic projection into underlying connective tissue
showing inflammatory cells and adipose tissue (Fig. 4),
suggestive of PVL, following which the lesions were
surgically excised, the H&E sections of the left buccal mucosa
showing squamous epithelium arranged in large sheets with
cellular polymorphism with prominent nucleoli and keratin
pearls, with report of well differentiated squamous cell
carcinoma, with a final diagnosis of PVL leading to
squamous cell carcinoma was attained at. Computed
tomography was done to rule out the bony involvement,
reveled no alveolar or bony involvement (Fig. 5).
TREATMENT
With deliberate discussions with oral surgeons, oncologist
and radiation oncologist, the patient was posted for radiation
therapy with Cobalt 60 teletherapy with a depth of 6 cm to
the head and 3.5 cm for the neck region with a total of
44 Gy. Postoperatively the patient developed trismus
(Fig. 6). Patient was given oral physiotherapy to elevate
the symptoms of trismus and antioxidants along with
benzalkonium oral rinse has been prescribed to the patient.
The postoperative response has been excellent in this case
with no recurrence of the lesion in the 1.5 year follow-up.
DISCUSSION
Oral leukoplakia (leuko = white; plakia = patch) is defined
by the World Health Organization (WHO) as ‘a white patch
Fig. 4: H&E showing epithelial proliferation in the form of exophytic
projections covered by hyper orthokeratotic stratified squamous
epithelium and, in few areas, there is a endophytic projection in to
underlying connective tissue showing inflammatory cells and
adipose tissue
Fig. 5: Axial computed tomography showing no involvement of the bone
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or plaque that cannot be characterized clinically or
pathologically as any other disease.’ The term is strictly a
clinical one and does not imply a specific histopathological
tissue alteration. Oral leukoplakias, where the white
component is dominated by papillary projections, similar
to oral papillomas, are referred to OVL. Oral leukoplakias
with this clinical appearance but with a more aggressive
proliferation pattern and recurrence rate are designated as
PVL. The malignant potential is very high in PVL.5 PVL is
a rare with an incidence of less than1% of adults in United
States with no data on the worldwide incidence is reported,
and is often seen in middle aged and elderly women,
occurring predominately on the buccal mucosa, palate,
gingiva and tongue.1 Hansel et al described PVL as an entity
that is difficult to treat effectively, because of multiple
recurrences and the appearance of new lesions.2 Hansel et al
classified the pathological process of PVL into 10 grades,
i.e. normal oral mucosa (0), homogenous leukoplakia (2),
verrucous hyperplasia (4), verrucous carcinoma (6),
papillary squamous cell carcinoma (8), and poorly
differentiated carcinoma (10), in which the odd scores refer
to a status intermediate between those referred to by the
adjacent even scores.1
The etiology of PVL is unclear, however role of tobacco
and alcohol has been documented as potential causes of
this lesion, but human papilloma virus (HPV) particularly
HPV16, may play an important role, though Began et al
failed to find any such association.6,7 PVL usually presents
as a solitary flat homogenous leukoplakia with involvement
of multiple sites at the time of diagnosis.8,9 Whatever, may
be the initial presentation, recurrence after treatment is the
rule. Soon after first treatment the lesions appear again, not
only at the previous site but also at new sites–the gingiva
being affected sites, hence the term PVL was introduced.9
The proliferative effect of PVL was explained on basis of
Fig. 6: Postradiotherapy with trismus
the high rate of field cancerization existing in PVL patients.
PVL exhibits persistent growth, eventually becoming
exophytic and verrucous in nature. As the lesions progress,
they may transform into full fledged squamous cell
carcinoma usually within 8 years of initial PVL presentation,
in our case the progression was very rapid and it transformed
into oral squamous cell carcinoma within 6 months, with
the massive extension of the lesion. Histopathologically,
PVL changes gradually from a simple plaque of
hyperkeratosis without dysplasia to verrucous hyperplasia,
followed by verrucous carcinoma and finally oral squamous
cell carcinoma.9
Clinical differential diagnosis would range from
frictional keratosis, homogenous leukoplakia, papilloma,
papillary hyperplasia, Cowden’s syndrome, verrucous
hyperplasia and verrucous carcinoma. The ambiguity of
PVL is further aggravated because there are no criteria that
dictate how extensive the leukoplakic changes should be or
how many or which oral subsites should be involved or
how many recurrences should have occurred in order to
qualify for the diagnosis of PVL.10 This lack of exact
diagnostic criteria is a prime reason due to which patients
of PVL do not get correct treatment. The treatment
modalities for PVL includes the use of multiple techniques
such as CO2 laser surgery, surgery associated with
radiotherapy, cryotherapy, retinoid A, systemic vitamin A
therapy, topical vitamins, bleomycin and photodynamic
therapy.8
CONCLUSION
PVL is a rare but highly aggressive, progressive from of
oral leukoplakia characterized by having a high risk of
malignant transformation. PVL grows slowly and can take
up to 7.8 years to become cancerous. The lack of exact
diagnostic criteria is a prime reason due to which patients
of PVL do not get correct treatment. Hence it is necessary
that the concept of PVL should be modified and quantified
so that a prompt and better treatment can be rendered to these
patients, thus improving their prognosis, warrants attention.
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